-
Product Quality and Safety at Bath Body Works Thu, 07/06/2023 - 10:55 Type of Content Blog Layout Standard Format Body We were founded on a simple idea: make the world a brighter, happier place through the power of fragrance. While our products are constantly evolving, what will never change is our dedication to providing our customers fragrances and formulas they can trust. From initial product development and formulation, product safety is our priority. Our personal care and home fragrance pro
-
Following massive progress on the Woolly Mammoth and Tasmanian tiger, Colossal launches Avian Genomics Group to continue groundbreaking de-extinction pursuits
-
The Extraordinary Grace keynote launch discusses the transformation and progress of DEI in STEM
-
Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced the addition of a companion diagnostic (CDx) indication to its CE-marked in vitro diagnostic TruSight™ Oncology (TSO) Comprehensive (EU) test. This single test kit, recently launched across Europe, assesses multiple tumor genes and biomarkers to reveal the specific molecular profile of a patient's cancer.
-
Illumina Singapore, subsidiary of Illumina Inc (NASDAQ: ILMN) and Trivitron Healthcare, one of India's largest medical technology companies, have entered into a strategic partnership to develop and expand the use of next-generation sequencing (NGS)-based in-vitro diagnostic tests (IVD) in India.
-
Monica Pacheco's Humble Approach to Leadership Through Learning Wed, 03/02/2022 - 12:10 Type of Content Blog Layout Featured Media Body The first thing that strikes you when you meet Monica Pacheco is her enthusiasm about her work and the process of converting raw materials to glass packaging. Her face lights up as she describes her trajectory from her early student days in Colombia to her internship with O-I Glass and her first job with O-I after graduation. After that, she moved to Batch Furna
-
Illumina, Inc. (NASDAQ: ILMN) today announced a multi-year partnership with Agendia N.V., a world leader in precision oncology for breast cancer, to co-develop in vitro diagnostic (IVD) tests for oncology testing. The partnership is intended to advance the use of next-generation sequencing (NGS) for decentralized oncology testing and aligns with Illumina's approach to IVD partnerships in oncology. Agendia joins Illumina's growing portfolio of more than 30 IVD partners developing over 40 sequencin
-
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the company will donate 100,000 vials of Veklury® (remdesivir) to help address the recent surge of COVID-19 cases in Indonesia and 3,000 vials of Veklury to help patients hospitalized with COVID-19 in Armenia. “As cases of COVID-19 surge again around the world, and the pandemic continues to affect the lives of so many, we remain focused on ensuring that our medicines can reach patients that need them,” said Johanna Mercier, Chief Commerci
-
-
Nonprofit Testing for America is advising historically black colleges and universities (HBCUs) in their COVID-19 testing strategies to support a safe reopening
-
Siemens Foundation, Siemens Healthineers and Siemens employees have donated more than $5.4 million in response to COVID-19 to advance healthcare equity in underserved communities
-
This initiative is also supported by the global Siemens relief fund program that was set up to help combat the COVID-19 crisis
-
Locations chosen based on the needs of underserved communities most vulnerable to COVID-19, advancing the Foundation’s commitment to equity
-
Insurer to underwrite up to $50,000 in early-life coverage for
prospective parents